DIA Europe 2025
We connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation. Meet our team to learn how our consultative approach and deep experience can benefit your product across it’s lifecycle.
Our evidence development solutions provide expert-driven real-world evidence tailored to specialty patient populations to uncover more valuable insights, maximize commercial positioning, and optimize regulatory approval for the long-term value of your therapy. Meanwhile, our safety & risk management solutions build confidence for prescribers by providing unmatched expertise in patient safety, along with strategies and results that balance commercial goals with seasoned regulatory oversight. Meet our team at booth B4 to learn more!
Meet With Us There
Presentation
Innovation in Pharmacovigilance: CAR-T, Gene Therapies, and New Modalities
Alix Garcia & Irene Navarro
How has pharmacovigilance evolved to address the complexities of modern therapies? Initially focused on simpler medicines, pharmacovigilance now tackles sophisticated modalities like CAR T-cell and gene therapies. This session will explore the benefits of early risk profiling for CAR T-cell therapies and the harmonization of pharmacovigilance guidance for next-generation biologic therapies. The session will feature a panel discussion with industry and regulatory experts, who will discuss the challenges of maintaining an effective pharmacovigilance system capable of handling the complexities of new therapeutic advancements.
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
Outsourcing in Clinical Trials Southern California 2026
HUB and Specialty Pharmacy West Conference 2026
World Orphan Drug Congress 2026
Meet With Us There
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.